Does Medicare cover Oncotype DX prostate?

Does Medicare cover Oncotype DX prostate?

Medicare has established coverage for the Oncotype DX Prostate Cancer test for qualified Medicare patients with early-stage prostate cancer. Exact Sciences believes that every eligible man should have access to the information they need to make confident, informed decisions about their cancer treatments.

Is Oncotype DX for prostate cancer accurate?

Specifically, 288 of the 732 genes analyzed, or almost 40%, reliably predicted recurrence; and 198 of 732 (almost 40%) reliably predicted aggressive disease. Based these findings Oncotype DX appears to reliably predict the aggressiveness of prostate cancer at diagnosis.

What is Oncotype DX prostate test?

Oncotype DX GPS test is a genomic test, meaning that it measures the expression of certain genes in prostate cancer cells. 4. The results are reported as a Genomic Prostate Score (GPS) result, which can help you and your doctor make decisions about a management plan that’s best for you.

Can metastatic prostate cancer be cured?

Metastatic prostate cancer is an advanced form of cancer. There’s no cure, but you take steps to treat and control it. Most men with advanced prostate cancer live a normal life for many years.

Does insurance cover the Oncotype DX test?

Medicare and most private insurance carriers cover the Oncotype DX Breast Recurrence Score test for eligible patients with early-stage invasive breast cancer.

How much does Oncotype DX cost?

The Oncotype DX test costs about $4,000. For insurance- and payment-related questions, call 1-866-ONCOTYPE (1-866-662-6897) or email [email protected].

How much does Oncotype DX test cost?

Various forms of financial assistance and payment plans are available for people facing financial hardships or those who are uninsured or underinsured. The Oncotype DX test costs about $4,000.

What is a good Oncotype score?

A score of 15 or smaller means you have a low risk of the cancer returning if you get hormone treatment. You probably will not benefit from receiving chemotherapy. A score between 16 and 20 means you have a low to medium risk of the cancer returning if you get hormone treatment.

How do you order Oncotype DX?

STEP 1 – Get specimen kits Request specimen transportation kit boxes by contacting Customer Service at 866-ONCOTYPE (866-662-6897) or email us with your information. Kit orders usually arrive to you within 48 hours.

Who qualifies for Oncotype testing?

If you have been diagnosed with DCIS (non-invasive) breast cancer (Stage 0) or early-stage invasive breast cancer (Stage I-IIIa), you may be eligible for the Oncotype DX test, a unique genomic breast cancer test that looks at the activity of certain genes in your tumor to provide personalized information not available …

Should I have the Oncotype DX test?

When should I have the Oncotype DX test? You should have the test done when you and your doctor agree that the test results will be helpful for making decisions about chemotherapy treatment.

When is brachytherapy not recommended?

Permanent seed brachytherapy won’t be suitable if your cancer has spread to other parts of your body (advanced prostate cancer). It may not be suitable if you have a very large prostate. If you do have a large prostate you may be able to have hormone therapy before treatment to shrink your prostate.

Who is eligible for Oncotype?

You may be a candidate for the Oncotype DX breast cancer test if you are medically eligible for chemotherapy and: You have been recently diagnosed with anatomic stage I,II or IIIa invasive breast cancer. Your breast cancer is estrogen-receptor positive (ER+) Human Epidermal growth factor Receptor-negative (HER2-)